ACUT 0.29 Accustem Sciences Inc.
| Range: | 0.2707-0.8289 | Vol Avg: | 2600 | Last Div: | 0 | Changes: | 0.02 |
| Beta: | 3.14 | Cap: | 0.00B | Currency: | USD | Exchange: | PNK |
| Sector: | Healthcare | IPO: | Thu Mar 03 2022 | Empoloyees: | 3 | ||
| CUSIP: | 00444A101 | CIK: | 0001850767 | ISIN: | US00444A1016 | Country: | US |
| CEO: | Ms. Wendy E. Blosser | Website: | https://www.accustem.com | ||||
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. The company is based in New York, New York.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow